Evidence map›Paper›PMID 31487806›Full record

Trial reportNutrients2019

Whey Protein Combined with Low Dietary Fiber Improves Lipid Profile in Subjects with Abdominal Obesity: A Randomized, Controlled Trial.

Elin Rakvaag, Rasmus Fuglsang-Nielsen, Knud Erik Bach Knudsen, Rikard Landberg, Astrid Johannesson Hjelholt, Esben Søndergaard, Kjeld Hermansen, Søren Gregersen

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 5 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 5 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Effects of Short-Term Dietary Fiber Intervention on Gut Microbiota in Young Healthy People.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Protein, amino acids and obesity treatment.Reviews in endocrine & metabolic disorders · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Elin RakvaagDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark. elinrak1210@gmail.com.ORCID 0000-0002-7140-1034
Rasmus Fuglsang-NielsenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.
Knud Erik Bach KnudsenDepartment of Animal Science, Aarhus University, 8830 Tjele, Denmark.ORCID 0000-0001-8345-9236
Rikard LandbergDepartment of Biology and Biological Engineering, Chalmers University of Technology, 412 96 Gothenburg, Sweden.
Astrid Johannesson HjelholtDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.
Esben SøndergaardDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0001-8041-6994
Kjeld HermansenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.ORCID 0000-0002-0148-6394
Søren GregersenDepartment of Endocrinology and Internal Medicine, Aarhus University Hospital, 8200 Aarhus, Denmark.
Aarhus University Hospital · DKAarhus University · DKChalmers University of Technology · SESteno Diabetes Centers · DK

Funding

Innovationsfonden 4105-00002B
6 · The paper itself

Abstract

Abdominal obesity is associated with elevated postprandial triglycerides (TG), an independent risk factor for cardiovascular diseases. Previous studies show that whey protein (WP) and dietary fiber may separately reduce postprandial TG. However, few studies have investigated the long-term effects of WP and dietary fiber on postprandial TG. We aimed to investigate the separate and combined long-term effects of WP and dietary fiber from wheat bran on postprandial TG and markers of lipid metabolism in subjects with abdominal obesity. We conducted a 12-week, double-blind, randomized, controlled, parallel intervention study. In a 2 × 2 factorial design, 73 adults were randomized to receive 60 g/day of either WP hydrolysate or maltodextrin (MD) combined with high-fiber wheat bran products (HiFi; 30 g dietary fiber/day) or low-fiber refined wheat products (LoFi; 10 g dietary fiber/day). A high-fat meal test was conducted before and after the intervention. Sixty-five subjects were included in the final analyses. There were no differences between intervention groups in postprandial TG assessed as incremental area under the curve (iAUC). WP-LoFi had reduced postprandial TG assessed as total area under the curve (tAUC) and reduced fasting TG compared with all other groups, and reduced fasting apolipoprotein B-48 compared with MD-LoFi. There were no changes in lipoprotein lipase activity. Total cholesterol and apolipoprotein B-100 were reduced after WP intake compared with MD. Total cholesterol was increased after HiFi intake compared with LoFi. In conclusion, intake of WP in combination with low-fiber cereal products for 12 weeks had beneficial effects on postprandial TG tAUC and fasting TG, but not on postprandial TG iAUC in subjects with abdominal obesity. Combining WP with high-fiber wheat bran products did not improve lipid profile.

Indexed as

Obesity, AbdominalAdultAgedBlood GlucoseDietary FiberFemaleGlucagonHumansInsulinLipidsMaleMiddle AgedWhey ProteinsBlood GlucoseDietary FiberGlucagonInsulinLipidsWhey Proteinsabdominal obesitydietary fiberpostprandial lipemiatriglycerideswhey protein

Identifiers

PMID31487806
PMCPMC6770182
OpenAlexW2971521621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.